Mucosal healing with oral tacrolimus is associated with favorable medium- and long-term prognosis in steroid-refractory/dependent ulcerative colitis patients

Short-term efficacy of tacrolimus in steroid-refractory ulcerative colitis - experience in 130 patients

(2012) K. J. Schmidt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ABCB1 Single-Nucleotide Polymorphisms Determine Tacrolimus Response in Patients With Ulcerative Colitis

(2011) K R Herrlinger et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Double-blind, placebo-controlled trial of oral tacrolimus (FK506) in the management of hospitalized patients with steroid-refractory ulcerative colitis

(2011) Haruhiko Ogata et al.   INFLAMMATORY BOWEL DISEASES

Tacrolimus Therapy as an Alternative to Thiopurines for Maintaining Remission in Patients With Refractory Ulcerative Colitis

(2011) Shuji Yamamoto et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Outcomes and adverse events in children and young adults undergoing tacrolimus therapy for steroid-refractory colitis

(2010) Sheree Watson et al.   INFLAMMATORY BOWEL DISEASES

Novel endoscopic activity index is useful for choosing treatment in severe active ulcerative colitis patients

(2010) Makoto Naganuma et al.   JOURNAL OF GASTROENTEROLOGY

Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitis

(2008) S. YAMAMOTO et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of tacrolimus in refractory ulcerative colitis and Crohnʼs disease: A single-center experience

(2007) Aaron Benson et al.   INFLAMMATORY BOWEL DISEASES